APA

Kelly D. L., Wehring H. J., Earl A. K., Sullivan K. M., Dickerson F. B., Feldman S., McMahon R. P., Buchanan R. W., Warfel D., Keller W. R., Fischer B. A. & Shim J. (20140508). Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin). : BMC psychiatry.

Chicago

Kelly Deanna L, Wehring Heidi J, Earl Amber K, Sullivan Kelli M, Dickerson Faith B, Feldman Stephanie, McMahon Robert P, Buchanan Robert W, Warfel Dale, Keller William R, Fischer Bernard A and Shim Joo-Cheol. 20140508. Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin). : BMC psychiatry.

Harvard

Kelly D. L., Wehring H. J., Earl A. K., Sullivan K. M., Dickerson F. B., Feldman S., McMahon R. P., Buchanan R. W., Warfel D., Keller W. R., Fischer B. A. and Shim J. (20140508). Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin). : BMC psychiatry.

MLA

Kelly Deanna L, Wehring Heidi J, Earl Amber K, Sullivan Kelli M, Dickerson Faith B, Feldman Stephanie, McMahon Robert P, Buchanan Robert W, Warfel Dale, Keller William R, Fischer Bernard A and Shim Joo-Cheol. Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin). : BMC psychiatry. 20140508.